Randomized non-inferiority trial to compare trimethoprim/sulfamethoxazole plus rifampicin versus linezolid for the treatment of MRSA infection

Thertrimethoprim-Sulfamethoxazole for Methicillin-ResistantStaphylococcus aureus: A Forgotten Alternative?

(2014) G. Pappas et al.   JOURNAL OF CHEMOTHERAPY

The safety and efficacy of high-dose daptomycin combined with rifampicin for the treatment of Gram-positive osteoarticular infections

(2013) Kheeldass Jugun et al.   INTERNATIONAL ORTHOPAEDICS

Tedizolid Phosphate vs Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections

(2013) Philippe Prokocimer et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Tissue penetration and antimicrobial activity of standard- and high-dose trimethoprim/sulfamethoxazole and linezolid in patients with diabetic foot infection

(2013) G. E. Stein et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Burden of meticillin-resistant Staphylococcus aureus infections at a Swiss University hospital: excess length of stay and costs

(2013) M. Macedo-Viñas et al.   JOURNAL OF HOSPITAL INFECTION

Treatment of Methicillin-Resistant Staphylococcus aureus Infections with a Minimal Inhibitory Concentration of 2 μg/mL to Vancomycin: Old (Trimethoprim/Sulfamethoxazole) versus New (Daptomycin or Linezolid) Agents

(2012) Michelle L Campbell et al.   ANNALS OF PHARMACOTHERAPY

Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients

(2012) F. Pea et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Epidemiology of Methicillin-Resistant Staphylococcus aureus Carriage and MRSA Surgical Site Infections in Patients Undergoing Colorectal Surgery: A Cohort Study in Two Centers

(2012) Benedikt Huttner et al.   Surgical Infections

Comparison of serotonin toxicity with concomitant use of either linezolid or comparators and serotonergic agents: an analysis of Phase III and IV randomized clinical trial data

(2011) Jill M. Butterfield et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Molecular and Epidemiological Evaluation of Strain Replacement in Patients Previously Harboring Gentamicin-Resistant MRSA: Table 1.

(2011) Giulia De Angelis et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Rifampin Combination Therapy for Nonmycobacterial Infections

(2010) G. N. Forrest et al.   CLINICAL MICROBIOLOGY REVIEWS

Long-Term Follow-Up Trial of Oral Rifampin-Cotrimoxazole Combination versus Intravenous Cloxacillin in Treatment of Chronic Staphylococcal Osteomyelitis

(2009) G. Euba et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Efficacy and tolerance of rifampicin–linezolid compared with rifampicin–cotrimoxazole combinations in prolonged oral therapy for bone and joint infections

(2009) S. Nguyen et al.   CLINICAL MICROBIOLOGY AND INFECTION

Management of methicillin-resistant Staphylococcus aureus infections

(2009) J. Garau et al.   CLINICAL MICROBIOLOGY AND INFECTION

Update on the safety of linezolid

(2009) Eugenios I Metaxas et al.   Expert Opinion On Drug Safety

Adjunctive Use of Rifampin for the Treatment of Staphylococcus aureus Infections

(2008) Joshua Perlroth et al.   ARCHIVES OF INTERNAL MEDICINE

Linezolid versus glycopeptide or β-lactam for treatment of Gram-positive bacterial infections: meta-analysis of randomised controlled trials

(2007) Matthew E Falagas et al.   LANCET INFECTIOUS DISEASES